OFFICIAL LEGAL TITLE
Generic Substitution Noninterference Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_HR_7473.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2022-04-07.
What are the main provisions?
Key points include:
- Drug companies cannot give doctors gifts or tell them to prescribe only brand-name drugs if a generic is available.
- Doctors keep the freedom to choose the best drug for you based on medical judgment.
- Government agencies and states can take legal action and fine companies that break these rules.
- This could lead to more affordable prescription drug options for you.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Maloney, Carolyn B. [D-NY-12].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.